Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Bulletin Du Cancer|April 9, 2008
[Has the time arrived for gene expression use at the bedside?]Véronique D'Hondt, Martine Piccart, Christos SotiriouClinical Breast Cancer|May 27, 2008
HER2-positive breast cancer: from trastuzumab to innovatory anti-HER2 strategiesNicolas Whenham, Véronique D'Hondt, Martine J PiccartThe Oncologist|August 13, 2008
Selected combination therapy with sorafenib: a review of clinical data and perspectives in advanced solid tumorsLissandra Dal Lago, Véronique D'Hondt, Ahmad AwadaBiomolecules|December 16, 2020
Dual Role of the PTPN13 Tyrosine Phosphatase in CancerSoha Mcheik, Leticia Aptecar, Peter Coopman, et al.International Journal of Molecular Sciences|October 28, 2023
PTPN13 Participates in the Regulation of Epithelial-Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma CellsLeticia Aptecar, Carole Puech, Evelyne Lopez-Crapez, et al.Therapie|June 21, 2025
[Early non-compliance with oral anticancer drugs, a clinical pharmacy as key issue in onco-senology]Fanny Leenhardt, Pauline Ares, Alma Nicolai, et al.Cancer Reports (Hoboken, N.J.)|October 27, 2022
Hypnosis on patients treated with adjuvant chemotherapy for breast cancer: A feasibility studyMichel Fabbro, William Jacot, Marta Jarlier, et al.Oncotarget|December 10, 2017
High PTPN13 expression in high grade serous ovarian carcinoma is associated with a better patient outcomeVéronique D'Hondt, Magalie Lacroix-Triki, Marta Jarlier, et al.Gynecologic Oncology|June 25, 2003
Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancerFilomena Mazzeo, Martine Berlière, Joseph Kerger, et al.Pageof 5